LANDMARK CELEBRATION OF UBM INDIA’S 11TH EDITION OF CPHI & P-MEC INDIA

0
1254

CPhI & P-MEC India 2017 at a glance:
South Asia’s largest Pharma event
Held at two different venues i.e., MMRDA Grounds (BKC), Mumbai – 27th to 29th Nov ; the Bombay Exhibition Centre (Goregaon) – 28th to 30th Nov
1,500 + exhibitors, 40+ countries’ participation
Salient features include Supplier-Finder Desk, Innovation Gallery and Exhibitor Showcase

UBM India held its head high in pride at the launch of the grand 11th edition of its signature event, CPhI & P-MEC India 2017, one of the world’s leading pharma networking expos. This year’s marquee event had more than 1,500 + exhibitors, 40 + countries’ participation. The inauguration of CPhI-P-MEC 2017 occurred at MMRDA Grounds, Bandra Kurla Complex in the presence of an august gathering of industry leaders including Shri. Satish Wagh, Chairman, Chemexcil, Mr. Rahul Deshpande, Group Director, UBM India, Mr. Jime Essink, Chief Executive Officer, UBM Asia Ltd, Mr. Aasif Khan, Director, Fabtech Technologies, Mr. Rajendra Khimsaria, Director, Khimsaria Associates, Mr. Khaja Nizamuddin, Director, Pharmapack Packaging Equipment, Mr. Yogesh Mudras, Managing Director, UBM India and other key dignitaries. Alongside the expo, UBM India launched the second edition of the India Pharma Week (IPW), an attractive platter of more than ten trend-setting events that got off to a flying start on November 25. Focusing on the pillars of business, knowledge, leadership, innovation, recognition and networking in the pharma domain, the IPW includes a Plant Visit, Pharma Leaders’ Golf, Pre-Connect Congress, Women in Pharma – Power Breakfast, the India Pharma Awards, Networking Evening, a closed door CEO Roundtable and many more activities. The IPW has transformed the CPhI & P-MEC exhibition from a wall-bound show to one with considerable intellectual value addition. Originating from CPhI Worldwide, the CPhI & P-MEC India was first introduced in 2006. Today, it has become South Asia’s leading pharma meeting place, covering every step of the supply chain, from drug discovery to finished dosage. CPhI India is an industry platform encompassing CROs, CMOs and manufacturers of API, Generics, Excipients and Drug formulation, Fine chemicals, Biosimilars, Finished Formulations, Lab chemicals and Biotechnology. P-MEC, on the other hand, includes manufacturers of Pharma Machinery and Equipment, Analytical Equipment, Automation & Robotics, Packaging Equipment & Supplies, Plant/Facility Equipment,

Automation & Controls, Processing Equipment, RFID, Tableting / Capsule fillers, Clean room equipment, Filling equipment and Laboratory products.

The show has grown exponentially over the years, with domestic and foreign exhibitors and visitors engaging over significant levels of business. This year, the expo comprised exciting facets such as the Supplier-Finder Desk (a digital floor plan that enabled visitors find exhibitors based on services or company names), Innovation Gallery (an arena where participating pharma companies were encouraged to showcase innovations on an international platform) and Exhibitor Showcase (a platform where exhibitors demonstrated how their new product launches are going to be efficacious.)

Compounded annual growth being 17.6%; Indian pharma is expected to be worth 55 billion USD by 2020. In line with this, the life science sector in India is also expected to employ close to 3.5 million people by 2022, a 100% increase in under a decade.

Leave a Reply